K-V Files For Ch. 11 As $45M Hologic Bill Comes Due
Women's health care company K-V Pharmaceutical Co. filed for Chapter 11 protection Saturday in New York, citing its inability to realize full value on its biggest product, preterm-birth drug Makena, and...To view the full article, register now.
Already a subscriber? Click here to view full article